Label Value
DOI 10.1038/s41388-019-0708-7
TITLE Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2019-05-22T02:30:31.256441
Web of Science Yes 2019-06-06T03:39:28.651699
Compendex No 2019-12-19T09:40:14.139833